Clinical trials with tumor antigen genetically modified dendritic cells.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Seminars in Oncology

• Publication date

  2005-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1053/J.SEMINONCOL.2005.09.002PMID 16338421
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Functional Analysis

  2023cited by this paper
• Telomerase mRNA-Transfected Dendritic Cells Stimulate Antigen-Specific CD8+ and CD4+ T Cell Responses in Patients with Metastatic Prostate Cancer 1

  2005cited by this paper
• Phase I Study of Immunization with Dendritic Cells Modified with Fowlpox Encoding Carcinoembryonic Antigen and Costimulatory Molecules

  2005cited by this paper
• Results of a phase I study utilizing monocyte‐derived dendritic cells pulsed with tumor RNA in children with stage 4 neuroblastoma

  2005cited by this paper
• Activation of the T-cell oncogene LMO2 after gene therapy for X-linked severe combined immunodeficiency.

  2004cited by this paper
• Toll-like receptors and dendritic cells: for whom the bug tolls.

  2004cited by this paper
• Boosting T Cell-Mediated Immunity to Tyrosinase by Vaccinia Virus-Transduced, CD34+-Derived Dendritic Cell Vaccination

  2004cited by this paper
• Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

  2004cited by this paper
• Tumor-specific human CD4+ regulatory T cells and their ligands: implications for immunotherapy.

  2004cited by this paper
• Results of a phase 1 study utilizing monocyte-derived dendritic cells pulsed with tumor RNA in children and young adults with brain cancer.

  2004cited by this paper
• Toll-like receptors and dendritic cells: for whom the bug tolls.

  2004cited by this paper
• Human Dendritic Cell Maturation by Adenovirus Transduction Enhances Tumor Antigen-Specific T-Cell Responses

  2004cited by this paper
• Immunological and clinical responses in metastatic renal cancer patients vaccinated with tumor RNA-transfected dendritic cells.

  2003cited by this paper
• Defective CD8 T Cell Memory Following Acute Infection Without CD4 T Cell Help

  2003cited by this paper
• Current developments in cancer vaccines and cellular immunotherapy.

  2003cited by this paper
• CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes

  2003cited by this paper
• Immunotherapy with Autologous, Human Dendritic Cells Transfected with Carcinoembryonic Antigen mRNA

  2003cited by this paper
• LMO2-Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1

  2003cited by this paper
• Autologous dendritic cells transfected with prostate-specific antigen RNA stimulate CTL responses against metastatic prostate tumors.

  2002cited by this paper
• DNA and RNA Modified Dendritic Cell Vaccines

  2002cited by this paper
• Immunologic Monitoring of Cancer Vaccine Therapy: Results of a Workshop Sponsored by the Society for Biological Therapy

  2002cited by this paper
• Cancer immunotherapy using gene-modified dendritic cells.

  2002cited by this paper
• Mucin gene (MUC1) transfected dendritic cells as vaccine: results of a phase I/II clinical trial

  2002cited by this paper
• Hypopigmentation associated with an adenovirus-mediated gp100/MART-1-transduced dendritic cell vaccine for metastatic melanoma.

  2002cited by this paper
• Progress in human tumour immunology and immunotherapy

  2001cited by this paper
• The HLA system. First of two parts.

  2000cited by this paper
• Comparative Analysis of Genetically Modified Dendritic Cells and Tumor Cells as Therapeutic Cancer Vaccines

  2000cited by this paper
• Review: Gene-Modified Dendritic Cells for Use in Tumor Vaccines

  2000cited by this paper
• Recombinant Adenovirus Induces Maturation of Dendritic Cells via an NF-κB-Dependent Pathway

  2000cited by this paper
• Murine dendritic cells infected with adenovirus vectors show signs of activation

  2000cited by this paper
• The HLA system. Second of two parts.

  2000cited by this paper
• Stimulatory and inhibitory differentiation of human myeloid dendritic cells.

  2000cited by this paper
• Murine dendritic cells transduced with an adenoviral vector expressing a defined tumor antigen can overcome anti-adenovirus neutralizing immunity and induce effective tumor regression.

  1999cited by this paper
• Alpha-fetoprotein-specific genetic immunotherapy for hepatocellular carcinoma.

  1999cited by this paper
• Murine dendritic cells transfected with human GP100 elicit both antigen‐specific CD8+ and CD4+ T‐cell responses and are more effective than DNA vaccines at generating anti‐tumor immunity

  1999cited by this paper
• Therapy of established tumour with a hybrid cellular vaccine generated by using granulocyte–macrophage colony‐stimulating factor genetically modified dendritic cells

  1999cited by this paper
• Enhanced immune response to the melanoma antigen gp100 using recombinant adenovirus-transduced dendritic cells.

  1999cited by this paper
• α-Fetoprotein-specific Genetic Immunotherapy for Hepatocellular Carcinoma

  1999cited by this paper
• Induction of antitumor immunity with dendritic cells transduced with adenovirus vector-encoding endogenous tumor-associated antigens.

  1999cited by this paper
• Dendritic cell vaccines for cancer immunotherapy.

  1999cited by this paper
• Cross-presentation: a general mechanism for CTL immunity and tolerance.

  1998cited by this paper
• Dendritic cells and the control of immunity

  1998cited by this paper
• T-cell help for cytotoxic T lymphocytes is mediated by CD40–CD40L interactions

  1998cited by this paper
• Genetic immunization for the melanoma antigen MART-1/Melan-A using recombinant adenovirus-transduced murine dendritic cells.

  1997cited by this paper
• CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to granulocyte-macrophage colony-stimulating factor plus tumor necrosis factor alpha: II. Functional analysis.

  1997cited by this paper
• Dendritic cells infected with poxviruses encoding MART-1/Melan A sensitize T lymphocytes in vitro.

  1997cited by this paper
• Bone Marrow–generated Dendritic Cells Pulsed with Tumor Extracts or Tumor RNA Induce Antitumor Immunity against Central Nervous System Tumors

  1997cited by this paper
• Dendritic Cells Transduced with an Adenoviral Vector Encoding a Model Tumor-Associated Antigen for Tumor Vaccination

  1997cited by this paper
• Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability.

  1997cited by this paper
• Virus-mediated delivery of antigenic epitopes into dendritic cells as a means to induce CTL.

  1997cited by this paper
• A comparison of gene transfer methods in human dendritic cells.

  1997cited by this paper
• Antigen analogs as tools to study T-cell activation function and activation.

  1996cited by this paper
• Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability.

  1996cited by this paper
• Dendritic cells and immune-based therapies.

  1996cited by this paper
• Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo

  1996cited by this paper
• Dendritic cells and immune-based therapies.

  1996cited by this paper
• Vaccination of patients with B–cell lymphoma using autologous antigen–pulsed dendritic cells

  1996cited by this paper
• MHC molecules as peptide receptors.

  1993cited by this paper

• Allogeneic mRNA-based electrotransfection of autologous dendritic cells and specific antitumor effects against osteosarcoma in rats

  2012cites this paper
• Monocytes transduced with lentiviral vectors expressing hepatitis C virus non-structural proteins and differentiated into dendritic cells stimulate multi-antigenic CD8(+) T cell responses.

  2010cites this paper
• Specific antitumor effects of tumor vaccine produced by autologous dendritic cells transfected with allogeneic osteosarcoma total RNA through electroporation in Rats

  2009cites this paper
• Dendritic cell vaccination as a treatment modality for melanoma

  2009cites this paper
• Fucoidan stimulation induces a functional maturation of human monocyte-derived dendritic cells.

  2008cites this paper
• Engineered CCR5 superagonist chemokine as adjuvant in anti-tumor DNA vaccination.

  2008cites this paper
• Molecular imaging of cell-mediated cancer immunotherapy.

  2006cites this paper
• Ethanol Exposure and Dendritic Cell Function

  2006cites this paper
• Update on immunotherapy for melanoma.

  2006cites this paper